Based on the differential AT expression patterns of these four genes (trdn, hspb7, elovl6, and kcnj15), we propose a deeper investigation with respect to distinct AT depots to determine if manipulating the expression/function of these genes may resolve VAT dysfunction in obesity. The gene discussed is TRDN; the disease is obesity due to melanocortin 4 receptor deficiency.